Skip to content

Natural History Study of Serious Medical Events in PWS

Non-Interventional, Observational, Natural History Study of Serious Medical Events in Prader-Willi Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03718416
Acronym
PATH for PWS
Enrollment
700
Registered
2018-10-24
Start date
2018-09-28
Completion date
2024-01-31
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prader-Willi Syndrome

Keywords

observational, non-interventional, Prader-Willi syndrome, PWS

Brief summary

PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.

Detailed description

Every 6 months, participants or their caregivers will be asked to update online surveys about medical problems and serious medical events, as well as provide information about conditions and behaviors often associated with PWS such as hyperphagia. Because this is an observational study, no study drug will be provided and no visits to a doctor or clinic are required.

Interventions

None listed

Sponsors

Prader-Willi Syndrome Association USA
CollaboratorOTHER
Foundation for Prader-Willi Research Canada
CollaboratorUNKNOWN
Prader-Willi Research Foundation Australia
CollaboratorUNKNOWN
Prader-Willi Syndrome Association
CollaboratorOTHER
Foundation for Prader-Willi Research
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants must meet all of the following criteria: * Confirmed diagnosis of PWS * At least 5 years of age * Live in the United States, Canada, Australia, or New Zealand * Must be enrolled or willing to enroll in the Global PWS Registry (https://pwsregistry.org) Participants or their caregiver must also meet all of the following criteria: * Have access to the internet to complete online surveys at least every 6 months * Agree to receive reminders to complete online surveys * Allow the staff to ask questions about survey responses if more information is needed and to enter data into the surveys

Exclusion criteria

Participants or their caregiver meeting any of the following criteria will be excluded: * Is not able to read and understand English

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the incidence of serious medical eventsUp to 4 yearsSerious medical events are those that result in death, are life-threatening, require hospitalization or an emergency room visit, or are medically significant

Secondary

MeasureTime frameDescription
Analyze D-dimer concentrations in a subset of participants who agree to provide a blood sampleUp to 4 yearsD-dimer is a protein in the blood that is present when a blood clot is forming or has formed
Evaluate prescription medication use associated with serious medical events and thrombotic eventsUp to 4 years
Evaluate the change in weightUp to 4 years
Evaluate the change in heightUp to 4 years
Evaluate the change in height-adjusted weightUp to 4 years
Evaluate the incidence of non-serious thrombotic eventsUp to 4 yearsThrombotic events include blood clots in a blood vessel, such as an artery or vein
Evaluate the pattern of hyperphagia behaviors using an online surveyUp to 4 yearsHyperphagia means the intense, constant hunger that often occurs in individuals with PWS
Evaluate hyperphagia management using an online surveyUp to 4 years
Evaluate food-related behaviors using an online surveyUp to 4 years
Analyze medical information to evaluate the natural history of PWSUp to 4 yearsMedical information will be from birth to before enrolling in the study
Evaluate PWS complexity using an online surveyUp to 4 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026